Document Type : Original Article

Authors

1 Department of Agronomy and Plant Breeding, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Ardabil, Iran

2 Department of biology, Payame Noor University (PNU), P.O.Box, 19395-4697 Terhran, Iran

Abstract

Autophagy is an effective regulatory process for eliminating tumors and worn-out intracellular components. Different groups of enzymes and regulatory elements are involved in the autophagy process. MAP1LC3A and BECN1 genes are the most important gene groups in autophagy. These genes, through the production of beclin-1 and lc3 proteins, are involved in the production of autophagosomes. In general, both MAP1LC3A and BECN1 genes are active in cellular responses and the biological process. The aim of this study was bioinformatics analysis at the level of genome and proteome and to evaluate and compare the expression of MAP1LC3A and BECN1 genes in different human body tissues. The results of this study showed that the expression level of the BECN1 gene was relatively higher than the MAP1LC3A gene in different mammals. Cell analysis of MAP1LC3A and BECN1 genes by antibodies that bind to proteins of target genes showed that the protein encoded by the BECN1 gene is more present in the cytosol and the proteins encoded by MAP1LC3A gene are locally present in vesicles. It was also found that the protein encoded by the MAP1LC3A gene had a higher expression in brain tissues than in other tissues, while the beclin-1 protein in cardiac tissue showed higher expression than in other tissues. Finally, by using this information, it is possible to provide the ground for targeted therapies.  

Graphical Abstract

Bioinformatics analysis of microtubule-associated protein-1 light chain 3 (MAP1LC3A) and (BECN1) genes in autophagy

Keywords

Main Subjects

Selected author of this article by journal

ِDr. Alireza Mirzaei
University of Mohaghegh Ardabili

ORCID

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

  1. Fazeli-Nasab B, Sayyed RZ, Sobhanizadeh A (2021) In Silico Molecular Docking Analysis of α-Pinene: An Antioxidant and Anticancer Drug Obtained from Myrtus communis. Int J Cancer Manag 14(2):e89116. doi:https://doi.org/10.5812/ijcm.89116
  2. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T (2004) LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. Journal of cell science 117(13):2805-2812. doi:https://doi.org/10.1242/jcs.01131
  3. Lisiak N, Toton E, Rybczynska M (2018) Autophagy as a potential therapeutic target in breast cancer treatment. Current Cancer Drug Targets 18(7):629-639. doi:https://doi.org/10.2174/1568009617666171114143330
  4. Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxidants & redox signaling 20(3):460-473. doi:https://doi.org/10.1089/ars.2013.5371
  5. Nabavi SF, Sureda A, Dehpour AR, Shirooie S, Silva AS, Devi KP, Ahmed T, Ishaq N, Hashim R, Sobarzo-Sánchez E (2018) Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration. Biotechnology advances 36(6):1768-1778. doi:https://doi.org/10.1016/j.biotechadv.2017.12.001
  6. Sharma R, Yadav R, Manivannan E (2012) Study of effect of Stevia rebaudiana bertoni on oxidative stress in type-2 diabetic rat models. Biomedicine & Aging Pathology 2(3):126-131. doi:https://doi.org/10.1016/j.biomag.2012.07.001
  7. Xu H-D, Qin Z-H (2019) Beclin 1, Bcl-2 and Autophagy. In: Qin Z-H (ed) Autophagy: Biology and Diseases: Basic Science. Springer Singapore, Singapore, pp 109-126. doi:https://doi.org/10.1007/978-981-15-0602-4_5
  8. Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, Doench JG, Bennett L, Levine B (2021) Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proceedings of the National Academy of Sciences 118(5):e2020478118. doi:https://doi.org/10.1073/pnas.2020478118
  9. Orvedahl A, MacPherson S, Sumpter Jr R, Tallóczy Z, Zou Z, Levine B (2010) Autophagy protects against Sindbis virus infection of the central nervous system. Cell host & microbe 7(2):115-127. doi:https://doi.org/10.1016/j.chom.2010.01.007
  10. Ma X, Liu H, Murphy JT, Foyil SR, Godar RJ, Abuirqeba H, Weinheimer CJ, Barger PM, Diwan A (2015) Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress. Molecular and cellular biology 35(6):956-976. doi:https://doi.org/10.1128/MCB.01091-14
  11. Kang Y, Li Y, Zhang T, Chi Y, Liu M (2019) Effects of transcription factor EB on oxidative stress and apoptosis induced by high glucose in podocytes. International journal of molecular medicine 44(2):447-456. doi:https://doi.org/10.3892/ijmm.2019.4209
  12. Fink G, Szewczak-Harris A, Löwe J (2016) SnapShot: the bacterial cytoskeleton. Cell 166(2):522-522. e521. doi:http://dx.doi.org/10.1016/j.cell.2016.06.057
  13. Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. Nature reviews Molecular cell biology 10(9):597-608. doi:https://doi.org/10.1038/nrm2755
  14. Ziółkowska B, Woźniak M, Ziółkowski P (2016) Co-expression of autophagic markers following photodynamic therapy in SW620 human colon adenocarcinoma cells. Molecular medicine reports 14(3):2548-2554. doi:https://doi.org/10.3892/mmr.2016.5541
  15. Zhou X, Wong ST (2008) Computational systems bioinformatics and bioimaging for pathway analysis and drug screening. Proceedings of the IEEE 96(8):1310-1331. doi:https://doi.org/10.1109/JPROC.2008.925440
  16. Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR (2015) Autophagy in Huntington disease and huntingtin in autophagy. Trends in neurosciences 38(1):26-35. doi:https://doi.org/10.1016/j.tins.2014.09.003
  17. Sharma M, Rajendrarao S, Shahani N, Ramírez-Jarquín UN, Subramaniam S (2020) Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease. Proceedings of the National Academy of Sciences 117(27):15989-15999. doi:https://doi.org/10.1073/pnas.2002144117
  18. Giatromanolaki AN, St Charitoudis G, Bechrakis NE, Kozobolis VP, Koukourakis MI, Foerster MH, Sivridis EL (2011) Autophagy patterns and prognosis in uveal melanomas. Modern Pathology 24(8):1036-1045. doi:https://doi.org/10.1038/modpathol.2011.63
  19. Paul-Samojedny M, Pudełko A, Kowalczyk M, Fila-Daniłow A, Suchanek-Raif R, Borkowska P, Kowalski J (2015) Knockdown of AKT3 and PI3KCA by RNA interference changes the expression of the genes that are related to apoptosis and autophagy in T98G glioblastoma multiforme cells. Pharmacological Reports 67(6):1115-1123. doi:https://doi.org/10.1016/j.pharep.2015.04.012
  20. He H, Dang Y, Dai F, Guo Z, Wu J, She X, Pei Y, Chen Y, Ling W, Wu C (2003) Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. Journal of biological chemistry 278(31):29278-29287. doi:https://doi.org/10.1074/jbc.M303800200
  21. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B, Levine B (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. Journal of virology 72(11):8586-8596
  22. Liang X Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1:672-676
  23. Mutlu H, Mutlu S, Bostancıklıoğlu M (2021) Profiling of autophagy-associated microRNAs in the osteosarcoma cell line of U2OS. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 21(13):1732-1737. doi:https://doi.org/10.2174/1871520621666201202090128